Buprenorphine And Naloxone Tablet
Product Images NDC 42858-601

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 42858-601). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rhodes Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Buprenorphine 01)

Chemical structure of Buprenorphine shown as a molecular diagram representing the active ingredient in the product Buprenorphine and Naloxone tablets. The structure includes detailed rings and functional groups and is labeled with HCl indicating the hydrochloride salt form.*

FDA Label Image

Chemical Structure (Buprenorphine 02)

Chemical structure diagram of Buprenorphine hydrochloride dihydrate, showing its molecular framework with labeled atoms and functional groups, including hydroxyl (OH), ketone (O), and alkene features, representing the active ingredient in the product Buprenorphine and Naloxone sublingual tablets by Rhodes Pharmaceuticals LLC.*

FDA Label Image

Image (Buprenorphine 03)

An instructional illustration showing a person placing a sublingual tablet under their tongue. The diagram highlights the correct placement of the tablet on the lower gum beneath the tongue, consistent with sublingual administration directions for Buprenorphine and Naloxone tablets.*

FDA Label Image

Principal Display Panel (2 mg/0.5 mg Tablet Bottle Label)

Label for Buprenorphine and Naloxone Sublingual Tablets, USP, with strength 2 mg/0.5 mg. It is a prescription sublingual tablet product by Rhodes Pharmaceuticals LLC. The label includes dosage details, pharmacist instructions, storage conditions, and a warning against unlicensed use. The package contains 30 tablets.*

FDA Label Image

Principal Display Panel (8 mg/2 mg Tablet Bottle Label)

Buprenorphine and Naloxone sublingual tablets, USP, 8 mg/2 mg strength. The label shows a 30-tablet bottle container with directions for pharmacists to dispense the Medication Guide. It warns against use of loose tablets not in blister packaging and provides storage instructions. The labeler is Rhodes Pharmaceuticals LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.